The role of myeloid cells in cancer therapies (Q38875474)

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Phagocytosis of apoptotic cells in homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Regulation of macrophage development and function in peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Decisions about dendritic cells: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The emerging understanding of myeloid cells as partners and targets in tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Coordinated regulation of myeloid cells by tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tissue-resident macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Protective and pathogenic functions of macrophage subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The multifaceted biology of plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The journey from stem cell to macrophage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Recruitment and differentiation of conventional dendritic cell precursors in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Neutrophils and immunity: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Eosinophils: changing perspectives in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor-associated macrophages: from mechanisms to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophages and therapeutic resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

New insights into the multidimensional concept of macrophage ontogeny, activation and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Distribution of the CD68 macrophage/myeloid associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Real-Time Imaging Reveals Local, Transient Vascular Permeability, and Tumor Cell Intravasation Stimulated by TIE2hi Macrophage-Derived VEGFA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cysteine cathepsins: multifunctional enzymes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophage plasticity and polarization: in vivo veritas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Transcriptional regulation of macrophage polarization: enabling diversity with identity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

MicroRNA-mediated control of macrophages and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The prognostic landscape of genes and infiltrating immune cells across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Long-Term Survival for Patients With Non–Small-Cell Lung Cancer With Intratumoral Lymphoid Structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Origins of tumor-associated macrophages and neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

MET is required for the recruitment of anti-tumoural neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tryptophan hydroxylase-1 regulates immune tolerance and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

In colorectal cancer mast cells contribute to systemic regulatory T-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Mast cells are an essential hematopoietic component for polyp development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Detailed analysis of inflammatory cell infiltration in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Mast cell deficiency, a game of kit and mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Monocytes and macrophages: developmental pathways and tissue homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The cellular and molecular origin of tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Critical roles of interferon regulatory factor 4 in CD11bhighCD8alpha- dendritic cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

AACR centennial series: the biology of cancer metastasis: historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophages eliminate circulating tumor cells after monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Immune escape and survival mechanisms in circulating tumor cells of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Patrolling monocytes control tumor metastasis to the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Neutrophils support lung colonization of metastasis-initiating breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

TH2-Polarized CD4(+) T Cells and Macrophages Limit Efficacy of Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Doxorubicin eliminates myeloid-derived suppressor cells and enhances the efficacy of adoptive T-cell transfer in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Immunogenic cell death in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Type I and type II Fc receptors regulate innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The role of Fc-FcγR interactions in IgG-mediated microbial neutralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Inhibitory Fcγ receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

scFv antibody: principles and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

KIT oncogene inhibition drives intratumoral macrophage M2 polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The immune microenvironment confers resistance to MAPK pathway inhibitors through macrophage-derived TNFα

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

BRAF Inhibition Stimulates Melanoma-Associated Macrophages to Drive Tumor Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Targeting MET in cancer: rationale and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Inhibition of both BRAF and MEK in BRAF(V600E) mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Impact of MAPK Pathway Activation in BRAF(V600) Melanoma on T Cell and Dendritic Cell Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Activation of dendritic cells via inhibition of Jak2/STAT3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Studying the mononuclear phagocyte system in the molecular age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Myeloid suppressor cell depletion augments antitumor activity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Therapeutic siRNA silencing in inflammatory monocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Angiotensin II drives the production of tumor-promoting macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Suppression of inflammation by a synthetic histone mimic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Epigenetic regulation of macrophage polarization and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Histone deacetylase inhibitor LAQ824 augments inflammatory responses in macrophages through transcriptional regulation of IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cancer immunotherapy: sipuleucel-T and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Innate response activator B cells protect against microbial sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

STING: infection, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

STATs in cancer inflammation and immunity: a leading role for STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

In situ regulation of DC subsets and T cells mediates tumor regression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Injectable cryogel-based whole-cell cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Behavior of endogenous tumor-associated macrophages assessed in vivo using a functionalized nanoparticle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

In vivo cell-cycle profiling in xenograft tumors by quantitative intravital microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

IMMUNOLOGY. An interactive reference framework for modeling a dynamic immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cancer cell profiling by barcoding allows multiplexed protein analysis in fine-needle aspirates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Imaging macrophages with nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Hybrid PET-optical imaging using targeted probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Trial watch: Dendritic cell-based anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The bone marrow niche for haematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Myocardial infarction accelerates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

The spleen in local and systemic regulation of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80(+) Extratumoral Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Inhibition of CSF-1R supports T-cell mediated melanoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Immune mechanism of the antitumor effects generated by bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

31 March 2020

Eosinophils and cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Mast Cells Are Key Promoters of Contact Allergy that Mediate the Adjuvant Effects of Haptens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRC.2016.54

Aberrant expression of macrophage-associated antigens (CD68 and Ki-M1P) by Schwann cells in reactive and neoplastic neural tissue. Light- and electron-microscopic findings

31 March 2020

1 reference

12 December 2020

The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

1 reference

12 December 2020

Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide

1 reference

12 December 2020

Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer

1 reference

12 December 2020

The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients

1 reference

12 December 2020

Macrophage-colony stimulating factor (CSF1) predicts breast cancer progression and mortality

1 reference

12 December 2020

Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer

1 reference

12 December 2020